Increased number of shares and votes in Kinnevik
Kinnevik AB (publ) ("Kinnevik") today announced that as of 30 June 2020 the total number of shares in the company amounts to 278,121,044, and the total number of votes in the company amounts to 581,919,932.
The adjustment is due to the new issue of 1,218,800 reclassifiable, sub-ordinated, incentive shares (the “incentive shares”), divided into three classes during June 2020, which, in accordance with the resolution by the Annual General Meeting in May 2020, have been transferred free-of-charge to participants in Kinnevik's 2020 long-term share incentive plan.
As of 30 June 2020, the total number of shares in Kinnevik are divided into two classes of ordinary shares and eleven classes of incentive shares as follows:
- 33,755,432 ordinary shares of class A with ten votes each and 241,911,206 ordinary shares of class B with one vote each (of which Kinnevik holds 192,927 ordinary shares of class B in treasury), and
- 42,034 incentive shares of class D 2018, 100,172 incentive shares of class E 2018, 100,172 incentive shares of class F 2018, 297,258 incentive shares of class G 2018, 41,325 incentive shares of class D 2019, 116,325 incentive shares of class E 2019, 116,325 incentive shares of class F 2019, 421,995 incentive shares of class G 2019, 63,200 incentive shares of class C1 2020, 355,440 incentive shares of class C2 2020, and 800,160 incentive shares of class D 2020, with one vote each (of which Kinnevik holds 8,275 incentive shares of class C1 2020, 40,740 incentive shares of class C2 2020 and 124,365 incentive shares of class D 2020 in treasury).
This information is of such character, which Kinnevik AB (publ) shall disclose in accordance with the Financial Instruments Trading Act (Sw. lagen (1991:980) om handel med finansiella instrument). The information was distributed for disclosure, through the agency of the contact person set out below, at 08.00 CET on 30 June 2020.
For further information, visit www.kinnevik.com or contact:
Torun Litzén, Director Investor Relations
Phone +46 (0)70 762 00 50
Kinnevik is an industry focused investment company with an entrepreneurial spirit. Our purpose is to make people’s lives better by providing more and better choice. In partnership with talented founders and management teams we build challenger businesses that use disruptive technology to address material, everyday consumer needs. As active owners, we believe in delivering both shareholder and social value by building long-term sustainable businesses that contribute positively to society. We invest in Europe, with a focus on the Nordics, the US, and selectively in other markets. Kinnevik was founded in 1936 by the Stenbeck, Klingspor and von Horn families. Kinnevik’s shares are listed on Nasdaq Stockholm’s list for large cap companies under the ticker codes KINV A and KINV B.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Scandinavian Tobacco Group A/S udsteder EUR 300 millioner erhvervsobligationer18.9.2020 08:00:00 CEST | pressemeddelelse
Selskabsmeddelelse Nr. 27/2020 København, 18. september 2020 Scandinavian Tobacco Group A/S udsteder EUR 300 millioner erhvervsobligationer Denne meddelelse og indholdet heraf må ikke udleveres, offentliggøres eller distribueres, direkte eller indirekte, i USA, Canada, Japan eller Australien eller i nogen anden jurisdiktion, hvor udlevering, offentliggørelse eller distribution ville være ulovlig.Denne meddelelse udgør ikke et tilbud om at sælge eller en opfordring til at fremsætte tilbud om at købe nogen værdipapirer i Scandinavian Tobacco Group A/S eller STG Global Finance B.V. i USA, Canada, Japan eller Australien eller nogen anden jurisdiktion. STG Global Finance B.V., et helejet datterselskab til Scandinavian Tobacco Group A/S, har gennemført prisning af en udstedelse af en 5-års usikret erhvervsobligation garanteret af Scandinavian Tobacco Group A/S med en hovedstol på EUR 300 millioner, forfald i september 2025 og en kuponrente på 1,375 %. Udstedelsen blev overtegnet lidt over to
Saniona deltar i den virtuella konferensen Oppenheimer Fall Healthcare Life Sciences & MedTech Summit 202018.9.2020 08:00:00 CEST | Pressemelding
PRESSMEDDELANDE 18 september 2020 Saniona (OMX: SANION), ett biofarmaceutiskt företag med klinisk utveckling fokuserad på sällsynta sjukdomar, meddelar idag att företagets koncernchef och VD Rami Levin kommer att delta i ett virtuellt ”samtal vid brasan” i samband med konferensen Oppenheimer & Co. Fall Healthcare Life Sciences & MedTech Summit som anordnas 21-23 september 2020. Närmare uppgifter om det virtuella samtalet vid brasan presenteras nedan. Oppenheimer & Co. 2020 Fall Healthcare Life Sciences & MedTech Summit Datum: Tisdag 22 september 2020 Tid: 10.50 ET Länk till webbsändning: https://wsw.com/webcast/oppenheimer5/sanion.st/3751533 Samtalet vid brasan kommer att websändas live, och kan nås via sidan ”Intervjuer och webbsändningar” på Sanionas webbplats: https://saniona.com/se/investors/interviews-webcasts/. Efter livesändningen kommer samtalet att finnas arkiverat på Sanionas webbplats i ungefär 90 dagar. För mer information, var vänlig kontakta Trista Morrison, Chief Communi
Saniona to Participate in Oppenheimer’s Virtual 2020 Fall Healthcare Life Sciences & MedTech Summit18.9.2020 08:00:00 CEST | Press release
PRESS RELEASE September 18, 2020 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that Rami Levin, President and Chief Executive Officer of Saniona, will participate in a virtual fire side chat at the Oppenheimer & Co. Fall Healthcare Life Sciences & MedTech Summit being held September 21–23, 2020. Details on the virtual fire side chat are shown below. Oppenheimer & Co. 2020 Fall Healthcare Life Sciences & MedTech Summit Date: Tuesday September 22, 2020 Time: 10:50 a.m. ET Webcast Link: https://wsw.com/webcast/oppenheimer5/sanion.st/3751533 A live webcast of the fire side chat will be available in the Interviews & Webcasts section of the Saniona website found here: https://saniona.com/investors/interviews-webcasts/. After the live webcast, this event will remain archived on the Saniona website for approximately 90 days. For more information, please contact Trista Morrison, Chief Communications Officer. Mobile + 1 (781) 810 9227
Scandinavian Tobacco Group A/S issues EUR 300 million Corporate Bond18.9.2020 08:00:00 CEST | Press release
Company Announcement No. 27/2020 Copenhagen, 18 September 2020 Scandinavian Tobacco Group A/S issues EUR 300 million Corporate Bond The information contained herein is not a release, publication or distribution, directly or indirectly, in or into the United States, Canada, Japan or Australia or any other jurisdiction in which such release, publication or distribution would be unlawful.This announcement does not constitute an offer to sell or the solicitation of an offer to buy securities in Scandinavian Tobacco Group A/S or STG Global Finance B.V. in the United States, Canada, Japan or Australia or any other jurisdiction. STG Global Finance B.V., a wholly-owned subsidiary of Scandinavian Tobacco Group A/S, has successfully priced an issuance of a 5 year unsecured corporate bond for a principal amount of EUR 300 million with maturity in September 2025 and with a coupon of 1.375%. The issuance was more than two times oversubscribed. The bonds are guaranteed by Scandinavian Tobacco Group
Roche launches new quantitative antibody test to measure SARS-CoV-2 antibodies, to support the evaluation of vaccines18.9.2020 07:03:00 CEST | Press release
The new Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in patients who have been exposed to the virus. The test targets antibodies against the spike protein. This is the focus of vaccines in development and convalescent plasma therapy.1Using the Elecsys Anti-SARS-COV-2 S antibody test, together with the Elecsys Anti-SARS-CoV-2* test launched in May, can help to more effectively determine the percentage of a population who already have antibodies against SARS-COV-2. Basel, 18 September 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of its Elecsys® Anti-SARS-CoV-2 S antibody test for markets accepting the CE Mark. Roche has filed for Emergency Use Authorisation (EUA) from the U.S. Food and Drug Administration (FDA). The Elecsys Anti-SARS-CoV-2 serology test can be used to quantitatively measure antibodies in people who have been exposed to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and can p
IMCD acquires Finnish distributor of composite materials Kokko-Fiber18.9.2020 07:00:00 CEST | Press release
ROTTERDAM, The Netherlands (18 September 2020, 07:00 CET) – IMCD N.V. (“IMCD” or the “Company”), a leading distributor of speciality chemicals and ingredients, today announces that it has acquired 100% of the share capital of Oy Kokko-Fiber Ab (“Kokko-Fiber”), a leading supplier of fiber-reinforced plastic composite materials in Finland. Kokko-Fiber, founded in 1994, serves a broad customer base that includes many of the largest Finnish companies that use fiber-reinforced plastics in their operations. The company has five employees and generated a revenue of €9.0 million in 2019. Sami Valkama, Managing Director IMCD Finland, comments: “IMCD Finland was established 25 years ago and since then we have strived to offer our customers best-in-class solutions. We recognize the importance of the composite business in the Nordic region. With this acquisition, IMCD will not only expand and strengthen its relationship with other suppliers in the composites’ market, but it will be in an excellent